Results 101 to 110 of about 7,822 (173)

Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors. [PDF]

J Neurooncol
Elgehiny A, Fan AE, Frost M, He J, Gary SE, Osorio DS, Zaky W, Zhou L, Kang KD, Zhang Z, Fueyo J, Gomez-Manzano C, Thompson EM, Bernstock JD, Friedman GK.   +14 more
europepmc   +1 more source

Oncolytic Herpes Simplex Virus for Glioblastoma: Molecular Engineering, Tumor Microenvironment Barriers, and Clinical Translation. [PDF]

Curr Issues Mol Biol
Liu J, Wang Y, Gao Z, Liu T, Xu A, Li W, Li M, Song X, Guo B, Wang H, Lv W, Zhang J.   +11 more
europepmc   +1 more source

Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biology. [PDF]

Cancer Biol Ther
Liu X, Zhang H, Du R, Liu Z, Ren Y, Yang X.   +5 more
europepmc   +1 more source

CD73 blockade enhances antitumor efficacy of oHSV in solid tumors by increasing macrophage-mediated antigen presentation. [PDF]

J Immunother Cancer
Murphy SA, Li J, Sahu U, Swanner J, Lewis CT, Anchang B, Cui Y, Chiocca EA, Kaur B.   +8 more
europepmc   +1 more source

Cracking the shield: oncolytic viruses versus the tumor-immune fortress. [PDF]

Cancer Cell Int
El-Derby AM, Salem NT, Hesham N, Salem TZ.   +3 more
europepmc   +1 more source

Gamma-irradiated Newcastle disease virus: an alternative inactivated oncolytic virotherapy. [PDF]

Immunol Cell Biol
Kennedy EV, Chuah Y, Mostafa AH, Gates CJ, Foeng J, Norton TS, McColl SR, Comerford I, Davies JB, Hemmatzadeh F, Alsharifi M.   +10 more
europepmc   +1 more source

Thymopentin enhances adenoviral oncolytic therapy by regulating macrophages and CD8⁺ T cells. [PDF]

Commun Med (Lond)
Kong L, Liu K, Liu Y, Cui H, Wang P, Qiu J, Xin Q, Zhou D, Liu W, Zhao F, Wu J, Gu X, Wu J, Jiang C.   +13 more
europepmc   +1 more source

Strategically engineering an oncolytic herpes simplex virus to improve systemic delivery. [PDF]

Mol Ther Oncol
Fu X, Benedyk T, Zhang SX.
europepmc   +1 more source

PD-L1 Immuno-PET Reveals Systemic Effects of Localized Oncolytic Virotherapy in a Mouse Model of Head and Neck Cancer. [PDF]

J Nucl Med
Höbart J, Da Pieve C, Raes F, Borys D, Mączyńska J, Sharma G, Melcher AA, Harrington KJ, Kramer-Marek G.   +8 more
europepmc   +1 more source

Targeting IL-12 for pancreatic cancer immunotherapy: advances in delivery strategies and clinical translation. [PDF]

Front Immunol
Schlatter J, Wei W, Chen Y, Melse A, Wang Y, Guerra S, Oberholzer J.   +6 more
europepmc   +1 more source